0001415889-23-006441.txt : 20230411
0001415889-23-006441.hdr.sgml : 20230411
20230411170450
ACCESSION NUMBER: 0001415889-23-006441
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230410
FILED AS OF DATE: 20230411
DATE AS OF CHANGE: 20230411
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ragosa Mark
CENTRAL INDEX KEY: 0001835458
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38492
FILM NUMBER: 23813961
MAIL ADDRESS:
STREET 1: C/O KINIKSA PHARMACEUTICALS CORP.
STREET 2: 100 HAYDEN AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kiniksa Pharmaceuticals, Ltd.
CENTRAL INDEX KEY: 0001730430
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: D0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CLARENDON HOUSE
STREET 2: 2 CHURCH STREET
CITY: HAMILTON
STATE: D0
ZIP: HM11
BUSINESS PHONE: 7814399100
MAIL ADDRESS:
STREET 1: CLARENDON HOUSE
STREET 2: 2 CHURCH STREET
CITY: HAMILTON
STATE: D0
ZIP: HM11
4
1
form4-04112023_090443.xml
X0407
4
2023-04-10
0001730430
Kiniksa Pharmaceuticals, Ltd.
KNSA
0001835458
Ragosa Mark
C/O KINIKSA PHARMACEUTICALS, LTD.
CLARENDON HOUSE 2 CHURCH STREET
HAMILTON
D0
HM 11
BERMUDA
false
true
false
false
CHIEF FINANCIAL OFFICER
0
Class A Common Share
2023-04-10
4
M
0
2695
A
12506
D
Class A Common Share
2023-04-10
4
F
0
791
10.71
D
11715
D
Restricted Share Unit
2023-04-10
4
M
0
2695
0
A
Class A Common Share
2695
8082
D
Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.
The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 7, 2022.
/s/ Madelyn Zeylikman, Attorney-in-Fact
2023-04-11